Women with recurrent vulvovaginal candidiasis often demonstrate a down-regulation of cell-mediated immunity (CMI) to Candida albicans detected by a lack of cutaneous delayed-type hypersensitivity (DTH) to Candida antigens. However, the role of systemic CMI as a host defense mechanism against recurrent vulvovaginal candidiasis is not well understood, in part because of the lack of a well-defined murine model of vaginal candidiasis. The present study was undertaken to determine: (i) whether soluble Candida culture filtrate antigens (CaCF) could be used to induce and detect Candida-specific CMI in mice and (ii) whether these antigens would be useful in detecting systemic CMI in mice given an experimental Candida vaginal infection.
Recurrent vulvovaginal candidiasis (RVVC) is an opportunistic mucosal infection (39) . Candida species are the second most common cause of vaginal infections in otherwise healthy females (10) . An estimated 75% of all women will experience an episode of Candida vaginitis once in their lifetime, with up to 5% experiencing RVVC (20) (21) (22) . Candida albicans is the causative agent in approximately 85 to 90% of patients with symptomatic yeast vaginitis (15, 20, 28, 31) . Antimycotic agents, although highly effective for individual attacks, do not prevent recurrence in women with chronic vulvovaginal candidiasis or RVVC. Unlike infrequent episodes of vaginitis precipitated by pregnancy, oral contraceptives, uncontrolled diabetes mellitus, and particularly the use of antibiotics, there are no recognized exogenous predisposing factors for RVVC (38) . RVVC is presumed to result from diminished host defense mechanisms that increase susceptibility to symptomatic infection, including the enhanced conversion of C. albicans from vaginal commensal to pathogen. It has been postulated that RVVC results from a down-regulation of cell-mediated immunity (CMI) similar to the immunoregulatory events associated with chronic mucocutaneous candidiasis (1, 5, 13, 14, 18, 32, 35, 42) , which are often mediated by suppressor cells (13, 34, 35) .
The finding of reduced systemic CMI to Candida infection in women with RVVC (16, 19, 41, 43, 44) supports the contention that CMI is an important antifungal host defense mechanism at the mucosal level. In addition, the fact that vaginal candidiasis has been reported for 25% of human * Corresponding author.
immunodeficiency virus-infected women (36) emphasizes the importance of CMI in protection against Candida vaginal infection. However, little is known about how CMI functions as a natural mucosal defense mechanism in the vagina and how it is regulated.
Progress in understanding the role of CMI in vaginal candidiasis has been hampered by the lack of a well-defined animal model to study Candida-specific CMI during experimental C. albicans vaginal infections. Although an estrogendependent murine model of experimental Candida vaginitis has been available for several years (37, 40) , to date it has been used primarily to test the efficacy of antifungal agents and to study adherence of Candida species to epithelial cells. There is no information on the role of humoral or cellmediated immune mechanisms associated with experimental Candida vaginal infection or on whether immune responsiveness is demonstrable in vivo or in vitro. In contrast, the importance of CMI in gastrointestinal host resistance to C. albicans has been demonstrated in both humans (4, 11, 25) and animal models (2, 6-8, 12, 30) . The use of murine models has allowed the identification of both lymphocyte populations that protect against Candida gastrointestinal infection (7, 8, 12) and those that down-regulate Candida-specific CMI, thus creating susceptibility to infection (3, 17) . Additionally, athymic (2, 6) and severe combined immunodeficient (T-and B-cell-deficient) (30) mice have been particularly useful for studying susceptibility to gastrointestinal candidiasis.
The present study was undertaken to determine whether Candida-specific CMI, detected by delayed-type hypersensitivity (DTH), could be demonstrated in vaginally infected mice with a complex culture filtrate antigen of C. albicans.
MATERIALS AND METHODS
Mice. Female CBA/J (H-2') mice, 8 to 10 weeks of age, purchased from the Jackson Laboratory (Bar Harbor, Maine) were used throughout these studies.
Antigens. C. albicans culture filtrate antigens (CaCF) were prepared from C. albicans 3153 serotype A (3153A) (American Type Culture Collection, Rockville, Md.) according to the methods described for the production of Cryptococcus neofonnans culture filtrate antigen (CneF) (9) . Briefly, growth medium for C. albicans (50% Phytone-peptone) was prepared and dialyzed against H20 (12,000-to 14,000-molecular-weight exclusion) (Spectrum Industries, Houston, Tex.) for 5 h at 70°C. After overnight incubation at 4°C the dialysis tubing was removed, the dialysate was autoclaved, and sterile glucose (1%) was added. The dialysate medium was inoculated with a fresh blastoconidium broth culture of C. albicans 3153A (2 x 105/ml) and incubated in a shaker H20 bath at 25°C for 3 days. The supernatants from the culture were concentrated 10 To analyze the cell population responsible for DTH reactivity, 0.5 mg of either anti-L3T4 (anti-CD4, GK 1.5; American Type Culture Collection) or anti-Lyt 2 (anti-CD8, HB129; American Type Culture Collection) antibodies were administered to mice intravenously in 0.5 ml of PBS on days -1 and 3. Mice were immunized with CaCF-CFA on day 0. DTH reactivity was measured on day 7. To confirm the action of the antibodies in vivo, spleen cells from treated animals were labeled with fluorescein isothiocyanate-conjugated anti-CD4 or anti-CD8 antibodies and analyzed with a fluorescence-activated cell sorter. Results showed that compared with the numbers of CD4 and CD8 cells in spleens of PBS-treated mice, the number of CD4 cells in spleens of anti-CD4-treated mice was reduced by 70 to 75%, whereas the number of CD8 cells remained unchanged or was slightly augmented by the lack of CD4 cells. Similar results were obtained with anti-CD8-treated mice: the number of CD8 cells in the spleens was reduced by 68 to 70%, while the number of CD4 cells remained unchanged.
Demonstration of experimental murine Candida vaginal infection. Vaginitis in rodents is inducible only under conditions of pseudoestrus (37, 40 CFmed prepared similarly to the antigen (data not shown). DTH reactivity was not demonstrable in mice injected with PBS-CFA and footpad challenged with CaCF. Figure 1B shows the kinetics of footpad swelling after challenge of 6-day immunized mice. Significant footpad swelling in immunized mice declined from 0.45 + 0.02 mm at 4 h to 0.38 +-0.03 mm by 8 h and then increased to the maximum swelling (0.48 + 0.06 mm) at 24 h. Negligible DTH reactivity was detected 48 h after challenge in immunized mice. Footpad swelling in mice injected with PBS-CFA and challenged with CaCF steadily declined to near the baseline by 24 h and remained at the baseline throughout the 48-h period.
CaCF induces antigen-specific DTH reactivity. To determine whether the DTH reactivity induced by CaCF represented Candida-specific swelling responses, CaCF-CFAand HKB-immunized mice were tested for DTH reactivity to CaCF, Candida-related cell wall antigens, and an irrelevant fungal antigen. The results are illustrated in Fig. 2 monitored longitudinally for 10 weeks. The mean results from three infection studies are shown in Fig. 4 . In these studies, estradiol-treated mice given a vaginal inoculum of C albicans developed DTH reactivity within 1 week (increase in footpad thickness, 0.25 + 0.015 mm). DTH reactivity peaked at 2 weeks (0.33 + 0.055 mm) and was still at significant levels at 4 weeks (0.13 + 0.02 mm). Reactivity declined to negligible levels by 6 weeks and remained at low levels (0.10 to 0.12 mm) through 10 weeks (Fig. 4A) . Numbers of C. albicans blastoconidia quantitated from vaginal lavage cultures were at highest levels (105 + 104 CFU/100 ,ul of lavage fluid) through 1 week post-vaginal inoculation. By week 4 of infection, C. albicans levels declined eightfold to 1.2 x 104 CFU + 1.5 x 103 CFU/100 ,ul of lavage fluid. Levels of C. albicans remained at approximately 104 CFU through week 8 before declining to an average of 6 x 103 CFU by week 10 (Fig. 4B ). This represented a 16-fold decrease in vaginal Candida burden. Biweekly germ tube tests on randomly selected colonies from the vaginal lavage cultures confirmed that C. albicans was isolated from the mouse vaginas. Conversely, estrogen-treated mice inoculated vaginally with only PBS failed to develop DTH activity and the lavage fluid contained no C. albicans organisms, evidenced both by the lack of growth on Sabouraud dextrose agar and the lack of yeast elements in wet-mount slide preparations. For additional evidence of infection, histological sections prepared from randomly selected vaginas were stained with hematoxylin. Histological examination showed no evidence of hyphae in mice inoculated with PBS (Fig.  5A) , whereas hyphae were readily apparent in mice that received a vaginal inoculum of C. albicans (Fig. 5B) .
DISCUSSION
Whereas murine models have been useful in studying CMI to gastrointestinal candidiasis (2, 6, 7, 30) , to date animal models have not been employed to investigate Candidaspecific systemic CMI during vaginal candidiasis. The purpose of this study was to determine whether a multiantigen culture filtrate preparation of C. albicans could be used to detect and measure, by DTH (8, 12) , as well as with other fungal models of DTH, i.e., C. neofonnans (29) and Paracoccidioides brasiliensis (23) . The DTH reactivity was Candida-specific by virtue of crossreactivity with Candida antigens (MAN and HKB) but not with unrelated fungal antigens prepared from C. neoformans. Abrogation of DTH reactivity in mice treated with anti-CD4 antibodies but not anti-CD8 antibodies confirmed that CD4+ DTH T cells were responsible for eliciting DTH reactivity. Taken together, the results suggested that CaCF is capable of inducing classic CMI and would be useful to detect, quantitate, and characterize systemic Candidaspecific CMI during experimental Candida vaginitis.
Evidence for experimental Candida vaginitis in rodents during conditions of pseudoestrus (37, 40) comes from superficial association of hyphae with estrogen-mediated proliferation of epithelial layers of the vagina. This is detected by quantitation of C. albicans in vaginal lavages and by the presence of hyphae in both histological preparations of dissected vaginas and wet-mount slide preparations of undiluted lavage fluid. However, no data for CBA/J mice have been collected with respect to kinetics of murine vaginal infections (e.g., whether CMI is generated and can be quantitated during the course of infection) have been collected.
In this study, we confirmed that Candida vaginitis can be achieved in CBA/J (H-2k) mice under conditions of pseudoestrus. This particular strain was chosen because H-2k mice are less resistant to Candida infection than H-2d mice (26) , which allows the potential generation of immunity, and not so resistant that infection cannot occur. With this model, we provide evidence that systemic CMI is generated as a result of Candida vaginal infection and can be detected and quantitated longitudinally by DTH reactivity with CaCF as the challenge antigen. This is similar to results obtained with experimental models of gastrointestinal candidiasis in which systemic CMI is demonstrable following introduction of Candida spp. into the gastrointestinal tract (7, 8, 12) . The CMI responsiveness during vaginal infection, as detected by DTH reactivity, peaked 2 weeks after vaginal inoculation. This corresponded to 1 week after peak vaginal Candida burden was reached. It is noteworthy that peak levels of DTH reactivity in vaginally infected mice were equivalent to the peak level of DTH reactivity in mice immunized with CaCF-CFA, indicating that Candida antigens originating from the vagina can stimulate DTH reactivity similarly to those administered systemically with adjuvant. In contrast, however, to the short-lived pattern of DTH reactivity in CaCF-CFA-immunized mice (Fig. 1) , DTH reactivity in vaginally infected mice was still relatively high through 3 weeks of infection and was sustained at low levels for up to 10 weeks. This suggests that Candida antigens are continually being released at low levels throughout the period of infection, a possibility that is supported by the steady but slow decline in vaginal Candida burden throughout the 10-week period.
Although a steady decline in vaginal Candida burden was evident during the 10-week period, complete clearance of Candida organisms was rarely observed. The lack of clearance of Candida organisms in the presence of demonstrable systemic CMI may in part be due to the dominant pharmacological effect of estrogen, which provides an environment that facilitates the adherence (27) and proliferation (24) of Candida organisms. Hence, it is unclear from our data whether the infection-mediated systemic CMI is responsible for the declining numbers of Candida organisms and whether this acquired immunity would have more impact in a less dominant environment. It does appear, however, that some type of systemic and/or locally derived immune activity is txpressed in the vagina during the infection, since mononuclear-like and polymorphonuclear-like cells associated with yeast mycelium have been observed in wet-mount preparations of lavage fluid from infected anitnals but not from PBS treated animals (data not shown).
In summary, although the murine model of experimental Candida vaginitis has been used for several years to study biological interactions of Candida spp. and the efficacy of antifungal agents, it has never been carefully studied as a means of identifying the immune events associated with Candida vaginitis. The fact that systemic CMI reactivity is generated as a result of vaginal infection in mice and can be detected and reproducibly measured suggests that this model can be used to study the role of CMI as a possible defense mechanism in experimental Candida vaginitis. Accordingly, vaginal candidiasis can be studied in the presence of systemically derived Candida-specific DTH T cells to examine the protective role of systemic CMI for mucosal surfaces. Moreover, T-cell populations present in the local vaginal tissue during an infection and lymphokines produced at the systemic and local levels can be examined in detail. In relation to clinical RVVC, since susceptibility of RVVC patients to repeated episodes of vulvovaginal candidiasis has been associated with impaired CMI (16, 19, 41, 43, 44) , results generated from the murine model of experimental vaginal candidiasis may provide insight into the role of CMI in infections of mucosal surfaces of the vagina.
